What now? A critical evaluation of over 20 years of clinical and research experience with 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention Review

sustainable development goals

publication date

  • October 1, 2023

webpage

published in

keywords

  • 17-alpha hydroxyprogesterone caproate
  • personalized medicine
  • preterm birth
  • progestogens

volume

  • 5

issue

  • 10